These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3493272)

  • 1. Antinuclear antibodies during psoralens plus ultraviolet A (PUVA) therapy--are they worthwhile?
    Picascia DD; Rothe M; Goldberg NS; Roenigk HH
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 1):574-7. PubMed ID: 3493272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinuclear antibodies and oral methoxsalen photochemotherapy (PUVA) for psoriasis.
    Stern RS; Morison WL; Thibodeau LA; Kleinerman RA; Parrish JA; Geer DE; Fitzpatrick TB
    Arch Dermatol; 1979 Nov; 115(11):1320-4. PubMed ID: 389166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinuclear antibodies appearing during PUVA therapy.
    Bruze M; Ljunggren B
    Acta Derm Venereol; 1985; 65(1):31-6. PubMed ID: 2578703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinuclear antibodies and PUVA photochemotherapy.
    Kubba R; Steck WD; Clough JD
    Arch Dermatol; 1981 Aug; 117(8):474-7. PubMed ID: 6973321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinuclear antibodies are not induced by PUVA treatment in patients with uncomplicated psoriasis.
    Calzavara-Pinton P; Franceschini F; Rastrelli M; Manera C; Zane C; Cattaneo R; De Panfilis G
    J Am Acad Dermatol; 1994 Jun; 30(6):955-8. PubMed ID: 8188886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal connective tissue disease with antinuclear antibodies following PUVA therapy.
    Bruze M; Krook G; Ljunggren B
    Acta Derm Venereol; 1984; 64(2):157-60. PubMed ID: 6203306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subacute cutaneous lupus erythematosus during PUVA therapy for psoriasis: case report and review of the literature.
    Dowdy MJ; Nigra TP; Barth WF
    Arthritis Rheum; 1989 Mar; 32(3):343-6. PubMed ID: 2649111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic, immunofluorescent, and antinuclear antibody findings in PUVA-treated patients.
    Levin DL; Roenigk HH; Caro WA; Lyons M
    J Am Acad Dermatol; 1982 Mar; 6(3):328-33. PubMed ID: 7040505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinuclear antibodies in mice induced by long wave ultraviolet radiation (UVA).
    Bruze M; Forsgren A; Ljunggren B
    Acta Derm Venereol; 1985; 65(1):25-30. PubMed ID: 2578702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinuclear antibodies during Puva therapy.
    Bjellerup M; Bruze M; Forsgren A; Krook G; Ljunggren B
    Acta Derm Venereol; 1979; 59(1):73-5. PubMed ID: 84474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous melanomas in patients treated with psoralens plus ultraviolet A. A case report and the experience of the PUVA Follow-up Study.
    Gupta AK; Stern RS; Swanson NA; Anderson TF
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):67-76. PubMed ID: 3403747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinuclear antibodies and photosensitivity in lupus erythematosus--relevant in PUVA therapy?
    Tuffanelli DL
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 1):614-6. PubMed ID: 3493273
    [No Abstract]   [Full Text] [Related]  

  • 13. Dermatomyositis occurring during psoralen A (PUVA) therapy.
    Sinoway PA; Davidson CL; Callen JP
    J Rheumatol; 1994 Feb; 21(2):353-6. PubMed ID: 8182650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subacute cutaneous lupus erythematosus during psoralen ultraviolet A therapy.
    McGrath H; Scopelitis E; Nesbitt LT
    Arthritis Rheum; 1990 Feb; 33(2):302-3. PubMed ID: 2306303
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of therapeutic efficacy of topical PUVA, oral etretinate, and combined PUVA and etretinate for the treatment of psoriasis and development of PUVA lentigines and antinuclear antibodies.
    Takashima A; Sunohara A; Matsunami E; Mizuno N
    J Dermatol; 1988 Dec; 15(6):473-9. PubMed ID: 3074090
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver biopsies from patients with psoriasis related to photochemotherapy (PUVA): findings before and after 1 year of therapy in twelve patients. A blind study and review of literature on hepatotoxicity of PUVA.
    Nyfors A; Dahl-Nyfors B; Hopwood D
    J Am Acad Dermatol; 1986 Jan; 14(1):43-8. PubMed ID: 3950113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of ultraviolet light in the pathogenesis of systemic lupus erythematosus: case report and discussion of the literature].
    Pirner K; Rubbert A; Salinger R; Kalden JR; Manger B
    Z Rheumatol; 1992; 51(1):20-4. PubMed ID: 1574932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antinuclear antibodies and PUVA therapy].
    Cattaneo R; Pancera C; Fenini MG; Gavazzoni R; De Costanza F
    G Ital Dermatol Venereol; 1982; 117(4):207-10. PubMed ID: 6985322
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term use of psoralens and ultraviolet A for psoriasis: evidence for efficacy and cost savings.
    Stern RS
    J Am Acad Dermatol; 1986 Mar; 14(3):520-6. PubMed ID: 3958270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?
    Lindelöf B
    Drug Saf; 1999 Apr; 20(4):289-97. PubMed ID: 10230579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.